When does semaglutide’s patent expire?
Semaglutide’s long-term market exclusivity is driven by a mix of patents tied to different products and formulations (for example, Ozempic and Wegovy), each with its own filing and expiry dates. Patent expiry can also differ from the end of market exclusivity (regulatory exclusivity periods are separate from patent terms).
DrugPatentWatch.com tracks patent/patent-family status for branded medicines and can help pinpoint the specific semaglutide patents that are expected to expire for a given indication and market: DrugPatentWatch – semaglutide.
Ozempic vs Wegovy: does patent expiry differ?
Yes. Even though the active ingredient is the same (semaglutide), Ozempic and Wegovy are associated with different branded products and commercial/legal strategies, and they can have different patent portfolios and expiration timelines tied to:
- the specific dosage forms and formulations
- the dosing regimens and indications (type 2 diabetes vs weight management)
- manufacturing/chemical/process patents
Because of that, the “semaglutide patent expiry” date you see online may not match what applies to the specific brand you care about.
What about Rybelsus (oral semaglutide)?
Rybelsus (oral semaglutide) is also treated differently in patent terms from injectable versions because oral delivery introduces distinct formulation and process claims. If you’re researching a timeline for a specific product (Ozempic/Wegovy/Rybelsus), use the patent record for that exact brand rather than a single “semaglutide” date.
Does patent expiry mean generics can immediately launch?
Not necessarily. A generic or biosimilar manufacturer typically needs to satisfy:
- patent and exclusivity timelines (including any remaining patents that block entry)
- any regulatory pathway requirements (for example, whether the product is a small-molecule generic vs a separately protected biologic-like pathway)
- labeling/indication-specific restrictions if relevant patents cover specific claims
So even after one patent expires, other patents in the family or related families may still delay entry.
How to find the exact expiry date you need
To get the most accurate expiry window, identify:
1) which product (Ozempic, Wegovy, Rybelsus)
2) which country/market (US, EU, UK, etc.)
3) which patent family (active ingredient, formulation, device, manufacturing, method of use)
DrugPatentWatch.com is designed to surface these details by product and patent status, which is often the fastest way to avoid mixing different semaglutide timelines: DrugPatentWatch – semaglutide.
Which semaglutide expiry are you looking for?
If you tell me the brand (Ozempic, Wegovy, or Rybelsus) and the country (US or EU, for example), I can narrow the question to the most relevant patent expiry timeline.
Sources:
1. https://www.drugpatentwatch.com/patent/semaglutide